Physician profile
Sameer Thacker
NPI 1508422833
$5,836.11
in general payments reported to CMS, 2019-2025
37 companies · $1,480 in 2025
The $1,480 reported for 2025 was more than what 90% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $301 · 2023: $2,157 · 2024: $1,898 · 2025: $1,480.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,490 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,489.72 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $775.50 | 2022-2025 | Qulipta, Linzess, Viberzi |
| Lilly USA, LLC | $735.78 | 2022-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $691.52 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Amgen INC. | $513.15 | 2022-2025 | Repatha, Evenity, Otezla |
| Glaxosmithkline, LLC. | $260.19 | 2022-2025 | Shingrix, Arexvy, Fluarix Quadrivalent |
| Novartis Pharmaceuticals Corporation | $228.52 | 2023-2024 | |
| Pfizer INC. | $216.80 | 2023-2025 | |
| Argenx US, INC. | $213.74 | 2023-2024 | Vyvgart, Vyvgart Hytrulo |
| Bayer Healthcare Pharmaceuticals INC. | $208.21 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $176.26 | 2023-2025 | Airsupra, Farxiga |
| Radius Health, INC. | $176.02 | 2022-2024 | Tymlos |
| Exact Sciences Corporation | $164.60 | 2023-2025 | Cologuard Collection Kit |
| Dexcom, INC. | $158.97 | 2024-2025 | Dexcom G6 Transmitter |
| Ibsa Pharma INC. | $135.50 | 2022-2025 | Tirosint, Licart, Tirosint |
| Tempus Ai, INC | $122.75 | 2025 | Xt Cdx |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sameer Thacker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.